Ipca Labs incorporates new wholly owned arm in Federal Republic of Germany
Written By : Ruchika Sharma
Published On 2025-10-18 12:30 GMT | Update On 2025-10-18 12:30 GMT
Advertisement
Mumbai: Ipca Labs has announced that the Company has incorporated a wholly owned subsidiary named 'Ipca Pharmaceuticals GmbH' in the Federal Republic of Germany.
The newly formed subsidiary has an initial paid-up capital of €25,000.
The primary objective of Ipca Pharmaceuticals GmbH is to hold product registrations, participate in institutional and other business activities, and undertake the distribution of generic formulations across the country.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.